Prosecution Insights
Last updated: November 12, 2026

Delta 4 GmbH

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Delta 4 GmbH is currently active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This action is assigned to 1 distinct examiner, reflecting a very targeted prosecution effort. The portfolio is also confined to 1 distinct art unit, which suggests a specific technical focus for the company's current patent application. This streamlined structure allows for a direct approach to securing intellectual property rights. The data indicates that the company's current USPTO activity is highly concentrated.

The busiest examiner for the company is BARSKY, JARED, who is managing 1 pending office action. This single action constitutes the entirety of the company's current pending workload at the USPTO. With only 1 distinct examiner and 1 distinct art unit involved, the company's immediate patent prospects are concentrated in one place. Practitioners can focus their strategy on the specific requirements and feedback provided by this single examiner in their specialized art unit. The outcome of this pending action will be the primary determinant of the company's current patenting success.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BARSKY, JARED 1 50.2% +22.9%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18265233 CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) BARSKY, JARED 30d

Top Art Units

Art UnitApps
1628 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18265233 CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) BARSKY, JARED 1628 §103 Final Rejection 30d Pending Jun 02, 2023

Managing Delta 4 GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Delta 4 GmbH have?

Delta 4 GmbH has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Delta 4 GmbH applications?

Jared Barsky has the most, with 1 of Delta 4 GmbH's pending office actions.

What technology area are Delta 4 GmbH's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month